This inventor holds 2 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 1990-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1992
Title: The Innovative Contributions of Theresa K. Peterman
Introduction
Theresa K. Peterman is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of herbicide-resistant enzymes. With a total of 2 patents, her work has implications for agricultural practices and crop resilience.
Latest Patents
Theresa's latest patents focus on the expression of wild type and mutant glutamine synthetase in foreign hosts. The invention relates to a mutant glutamine synthetase (GS) enzyme that is resistant to inhibition by herbicidal GS inhibitors, such as phosphinothricin (PPT). This includes genetic sequences coding for the enzyme, as well as plant cells and prokaryotes transformed with these genetic sequences. The invention also encompasses herbicidal GS inhibitor-resistant plant cells and plants.
Career Highlights
Theresa K. Peterman is associated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve agricultural efficiency and sustainability.
Collaborations
Some of her notable coworkers include Howard M. Goodman and Shiladitya DasSarma, who contribute to her research endeavors and collaborative projects.
Conclusion
Theresa K. Peterman's innovative work in the field of biotechnology exemplifies the impact of scientific research on agriculture. Her patents reflect a commitment to developing solutions that enhance crop resilience against herbicides.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile